Australian Clinical Labs Limited (ACL) To Go Ex-Dividend on March 11th

Australian Clinical Labs Limited (ASX:ACL) declared a interim dividend on Tuesday, February 17th, MarketIndexAU Dividends reports. Stockholders of record on Monday, March 30th will be given a dividend of 0.037 per share on Monday, March 30th. This represents a dividend yield of 170.0%. The ex-dividend date of this dividend is Wednesday, March 11th.

Australian Clinical Labs Stock Performance

The company has a market capitalization of $411.34 million, a price-to-earnings ratio of 16.20, a price-to-earnings-growth ratio of -0.36 and a beta of 0.93. The company has a debt-to-equity ratio of 301.27, a current ratio of 0.59 and a quick ratio of 0.53.

Australian Clinical Labs Company Profile

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services.